The GLP-1 telehealth space has a credibility problem, and knowing how to sort the solid options from the sketchy ones matters more now than ever.
Early 2026 saw the FDA send warning letters to more than 30 telehealth and compounding operations. A March 2026 settlement between Novo Nordisk and several providers reshuffled which brands still offer compounded semaglutide at all. Prices range from $99 to over $399 per month depending on medication type, service model, and whether you use insurance. Before picking a name, pick your criteria.
How to Decide: The Four Questions That Actually Matter
1. Is the pharmacy named and verifiable? Generic “FDA-registered” language without a specific pharmacy name is a yellow flag. Look for a named 503A compounder with USP-797 compliance.
2. What does monitoring look like? Some platforms assign a board-certified clinician. Others route you through a fast intake form with minimal follow-up. Know which you’re getting.
3. Is the price the full price? Membership fees, lab fees, and shipping charges can easily double the advertised monthly number.
4. Are the efficacy claims honest? GLP-1 compounds are not FDA-approved medications. Any provider that implies otherwise, or claims equivalency to Ozempic or Wegovy by name, is already telling you something about how they operate.
Keep those four filters in mind as you read the entries below.
The 5 Most Trusted GLP-1 Providers
#1 HealthRX
Compounded semaglutide starts at $99 per month here, tirzepatide at $149. That is genuinely low compared to nearly every other cash-pay telehealth option on this list.
The pharmacy behind every shipment is Manifest Pharmacy in Greer, South Carolina, a 503A compounder operating under USP-797 standards with lot-level tracking from bench to your door. That name is publicly verifiable. HealthRX also holds LegitScript certification (certificate number 50087439), which requires ongoing compliance checks that most telehealth platforms skip entirely.
Turnaround is fast. A U.S. board-certified physician reviews your intake within roughly 24 hours, and medication ships overnight, free, to all 50 states. No contracts, no hidden platform fee buried in the fine print.
The clinical data they reference comes from published trials, not internal claims. The SURMOUNT-1 trial recorded approximately 21% average body weight reduction with tirzepatide over 72 weeks. The STEP 1 trial showed roughly 15% reduction with semaglutide over 68 weeks. These are the numbers HealthRX points to. Worth noting: these are trial results for the branded medications, not for compounded versions specifically.
For a cash-pay buyer who wants a named pharmacy, LegitScript verification, and no surprises on the bill, this is the most complete package at the lowest entry price.
*Quick honest aside: compounded GLP-1 medications are not FDA-approved products. Every provider on this list dispenses them under separate compounding regulations. Talk to a physician before starting any of these programs.*
#2 FormBlends
FormBlends costs more upfront. Per-vial pricing comes to about $299 for semaglutide and $349 for tirzepatide. Shipping covers 47 states, not 50.
So why does it belong on a trust list? The lab documentation. FormBlends publishes per-product purity testing with actual numbers: HPLC purity figures, mass spec identity confirmation, endotoxin and sterility results. Most compounding telehealth brands do not publish this data at all. The pharmacy is FDA-registered and 503A-compliant, physician oversight is built into the model, and the pricing is transparent per vial rather than bundled in a way that obscures the real cost.
There is also a broader catalog here. Peptides for recovery, cognitive support, and longevity sit alongside the GLP-1 options under the same clinician model. That makes FormBlends the more logical choice for someone who wants a single provider for GLP-1 therapy plus other peptide protocols. Not everyone needs that. But if published purity data or a wider peptide menu matters to you, this earns its place.
#3 Mochi Health
Mochi charges around $99 per month for compounded semaglutide and $199 for tirzepatide. The standout here is clinical staffing. Mochi uses board-certified obesity-medicine physicians, not general practitioners, which means more informed medication management for patients with complex metabolic histories. Monitoring is more involved than lighter platforms.
#4 Hims & Hers
After exiting compounded GLP-1s following the March 2026 Novo settlement, Hims & Hers now focuses on branded medications. Injectable Wegovy runs around $299 per month, Zepbound around $399, and oral options around $249. With insurance plus a savings card, some users get to $0 to $25 monthly. Best fit for someone who wants branded meds with insurance coordination and a known consumer brand behind the process.
#5 Ro Body
Ro’s first month costs $39, then roughly $74 to $149 per month, with medications billed separately. Ro operates a dedicated prior-authorization team for insurance coverage on branded drugs. For patients who have employer insurance that may cover GLP-1s, Ro’s insurance support process is one of the more structured among telehealth options.
Quick Comparison
| Provider | Entry Price (Compounded) | All 50 States | Named Pharmacy | Purity Data Published |
| HealthRX | $99/mo sema | Yes | Yes (Manifest, SC) | No |
| FormBlends | ~$299/vial sema | No (47 states) | Yes (503A registered) | Yes |
| Mochi Health | $99/mo sema | Yes | Not specified publicly | No |
| Hims & Hers | Branded only now | Yes | N/A | N/A |
| Ro Body | Meds billed separately | Yes | Not specified publicly | No |
Sources
- FDA warning letters to telehealth/compounding firms, early 2026 (FDA.gov enforcement actions)
- SURMOUNT-1 trial (tirzepatide), findings reported in *New England Journal of Medicine*, 2022
- STEP 1 trial (semaglutide), findings reported in *New England Journal of Medicine*, 2021
- LegitScript certification database (LegitScript.com)
- Novo Nordisk settlement coverage, March 2026 (Reuters, STAT News)
- USP-797 pharmaceutical compounding standards (USP.org)
